Trial Profile
Midostaurin does not prolong cardiac repolarization defined in a thorough electrocardiogram trial in healthy volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 30 Aug 2012
Price :
$35
*
At a glance
- Drugs Midostaurin (Primary) ; Moxifloxacin
- Indications Acute myeloid leukaemia; Systemic mastocytosis
- Focus Pharmacodynamics
- 30 Aug 2012 New trial record